HeadInvest LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$930K Buy
7,281
+2,415
+50% +$301K 0.19% 101
2025
Q4
$593K Buy
4,866
+270
+6% +$31K 0.12% 133
2025
Q3
$461K Sell
4,596
-250
-5% -$22.5K 0.1% 149
2025
Q2
$402K Sell
4,846
-36
-0.7% -$2.87K 0.09% 159
2025
Q1
$396K Sell
4,882
-115
-2% -$10.3K 0.08% 167
2024
Q4
$450K Buy
4,997
+235
+5% +$22.8K 0.08% 156
2024
Q3
$470K Buy
4,762
+362
+8% +$35.6K 0.09% 156
2024
Q2
$408K Buy
4,400
+685
+18% +$61.4K 0.08% 161
2024
Q1
$353K Buy
+3,715
New +$345K 0.07% 173
2023
Q4
Sell
-1,203
Closed -$85K 715
2023
Q3
$85K Buy
+1,203
New +$96.1K 0.02% 299

Other funds holding XBI